Overland ADCT is a biopharmaceutical company specialized in the development, production and commercialization of Antibody-Drug Conjugate (ADC) drugs. By bringing in the world's first-in-class, cutting-edge ADC drugs, and building a complete biopharma value chain that covers R&D through commercial, we are committed to developing and providing breakthrough and affordable therapies for cancer patients in the Greater China Region and Singapore.
Overland ADCT is committed to maximizing the medical and commercial value of innovative Antibody-Drug Conjugate (ADC) drugs to transform outcomes for patients. We strive to become a formidable and progressive force in the battle against cancer.
Overland ADCT is committed to providing cutting-edge innovative therapies for cancer patients in China at the fastest speed possible and working with different stakeholders to improve drug accessibility. We want to transform the treatment paradigm and offer new options to cancer patients.
Chief Executive Officer, Overland ADCT BioPharma